Artificial intelligence and anti-cancer drugs: advancing discovery, personalization, and precision oncology
Artificial intelligence (AI) is changing the way we discover anticancer drugs. It tackles the problems of traditional methods, such as prolonged timelines for drug development, higher costs, and substantial inter-patient heterogeneity. This review explains how AI is applied throughout the cancer drug pipeline. This inc...
Faizan ul Haque Nagrami, Pahchan Shukla, Ruchi Yadav et al.
· Frontiers in Oncology · 0 citations